Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
AGF U.S. Market Neutral Anti-Beta Fund (BTAL) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
AGF U.S. Market Neutral Anti-Beta Fund (BTAL) - free report >>
Image: Bigstock
Long/Short ETF (BTAL) Hits a New 52-Week High
For investors looking for momentum, AGFiQ US Market Neutral AntiBeta ETF (BTAL - Free Report) is probably a suitable pick. The fund hit a 52-week high and is up 21.6% from its 52-week low price of $16.15/share.
Let’s take a look at the fund and its near-term outlook to gain an insight into where it might be headed:
BTAL in Focus
The underlying Dow Jones U.S. Thematic Market Neutral Anti-Beta Index is a long / short market neutral index that is dollar-neutral. It has AUM of $108.8 million and its expense ratio is 2.53%.
Why the Move?
The Russia-Ukraine war, high inflation levels, the Federal Reserve’s aggressive stance on rate hikes and China’s zero-Covid ppolicy are keeping investors on edge, adding to the market gyrations this year. This is making defensive funds like BTAL an attractive investment option.
More Gains Ahead?
It seems like the fund will remain strong, with a positive weighted alpha of 17.90, which gives cues of a further rally.